---
title: "Mirum Pharmaceuticals (MIRM) Gets a Buy from Cantor Fitzgerald"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295104577.md"
description: "Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Mirum Pharmaceuticals (MIRM) with a $140 price target, while the stock closed at $105.79. The broader market consensus for MIRM is Strong Buy, with an average target of $140.43 implying 32.74% upside. Additionally, Citizens JMP also issued a Buy rating with a $137 target."
datetime: "2026-08-06T11:56:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295104577.md)
  - [en](https://longbridge.com/en/news/295104577.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295104577.md)
generator: "portal-rs"
---

# Mirum Pharmaceuticals (MIRM) Gets a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Mirum Pharmaceuticals yesterday and set a price target of $140.00. The company’s shares closed yesterday at $105.79.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Schimmer is a 5-star analyst with an average return of 19.0% and a 51.83% success rate. Schimmer covers the Healthcare sector, focusing on stocks such as ARS Pharmaceuticals, Nuvalent, and Artiva Biotherapeutics, Inc..

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Mirum Pharmaceuticals with a $140.43 average price target, representing a 32.74% upside. In a report released today, Citizens JMP also maintained a Buy rating on the stock with a $137.00 price target.

### Related Stocks

- [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md)
- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)
- [NUVL.US](https://longbridge.com/en/quote/NUVL.US.md)
- [ARTV.US](https://longbridge.com/en/quote/ARTV.US.md)
- [CFG.US](https://longbridge.com/en/quote/CFG.US.md)
- [CFG-I.US](https://longbridge.com/en/quote/CFG-I.US.md)
- [CFG-E.US](https://longbridge.com/en/quote/CFG-E.US.md)
- [CFG-H.US](https://longbridge.com/en/quote/CFG-H.US.md)

## Related News & Research

- [Mirum CEO Christopher Peetz sells 30,000 shares for $2.95 million](https://longbridge.com/en/news/297965657.md)
- [Mirum Pharmaceuticals (MIRM) Following Rare Disease Growth Narrative Looks Undervalued](https://longbridge.com/en/news/296924108.md)
- [Algert Global LLC Invests $3.94 Million in Mirum Pharmaceuticals, Inc. $MIRM](https://longbridge.com/en/news/297278462.md)
- [What is HC Wainwright's Forecast for MIRM FY2028 Earnings?](https://longbridge.com/en/news/294201985.md)
- [Mirum Pharmaceuticals (MIRM) Projected to Announce Quarterly Earnings on Thursday](https://longbridge.com/en/news/293574645.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**